Find a Tender
complete
Official procurement procedure
BOND RX VEAT Notice
Laboratory
optical and precision equipments (excl. glasses)
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: University Of Edinburgh: "BOND RX VEAT Notice". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | University Of Edinburgh | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: University Of Edinburgh
Market Analytics
Derived from OCDS awards & bid statistics
Published history for University Of Edinburgh. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
3.3Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 230 active published awards; 205 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityUniversity Of Edinburgh | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published4 Dec 2025, 15:52 GMT | Last source update4 Dec 2025, 15:52 GMT | Recurring procurementNot published |
ClassificationLaboratory, optical and precision equipments (excl. glasses) | ||
Delivery area | ||
OCIDocds-h6vhtk-05eefe | ||
What is being bought
The University of Edinburgh is seeking to award a contract for the purchase of a BOND RX without a tender process due to the belief that there is only one supplier who can meet our requirements. Please see below for further details.
What changed
From the official release history
- Status changed to complete
4 Dec 2025, 15:52 GMT - Official notice release published
4 Dec 2025, 15:52 GMT - Buyer information updated
4 Dec 2025, 15:52 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedStatus not publishedPublished valueNot publishedWe intend to award a contract to Leica for the purchase of the BOND RX based on the following: 1.Comprehensive Testing Capabilities: The BOND RX offers the extensive range of testing methods required, including IHC, IF, TSA, FISH, ISH, TUNEL, miRNA, bDNA, and multiplexing. No other known stainer currently provides all of these methods in a single instrument. This range of methods is critical to meet the diverse needs of our ongoing and future research. 2.Continuity of Research: We currently use the Leica BOND III, on which multiple users have developed specific protocols. In order to maintain continuity and avoid disruption to ongoing research, we require that these existing protocols be transitioned seamlessly to the new equipment. The BOND RX is compatible with this requirement, while stainers from other suppliers do not offer the same protocol compatibility. 3.Ready to Use Antibodies: Leica offers a range of "Ready to Use" antibodies, all pre-tested for use with their BOND stainers. This eliminates the need for titration when using new antibodies, streamlining the process and ensuring consistency across experiments. While the BOND RX is compatible with antibodies from other suppliers, Leica’s solution provides additional efficiency and reliability.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
4 Dec 2025, 15:52 GMT - Award active
Not published · Not published - Contract active
Signed 4 Dec 2025, 00:00 GMT · £190,388
Commercial outcome and competition
Awards Leica Microsystems (UK) Ltd Not published · Not published · active |
Contracts Contract £190,388 · signed 4 Dec 2025, 00:00 GMT · active |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
University Of Edinburgh
Contracting authority GB-FTS-2023Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleAfter comprehensive market engagement competition is absent for technical reasons. No reasonable alternative or substitute exists and the absence of competition is not the result of an artificial narrowing down of the parameters of the procurement.
This notice is the final piece of due diligence prior to the award of the contract. Should a supplier detail their ability to meet the requirements, then the award will be halted. |